Objective. To determine if scopolamine-induced cognitive impairment in healthy elderly people predicts cognitive decline 6 years later. Design. Prospective cohort study. Setting. Elderly care research unit. Participants. Healthy elderly people who were part of a volunteer panel of research subjects
Scopolamine-induced cognitive impairment as a predictor of cognitive decline in healthy elderly volunteers
β Scribed by Dr. Andrew Barker; Roy Jones; Pauline Simpson; Keith Wesnes
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 312 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0885-6230
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
There are theoretical grounds for believing that scopolamineβinduced cognitive deficit may be predictive of future cognitive decline. In the present study, 22 healthy elderly volunteers were reassessed 3 years after a scopolamine challenge. Although there was little overall change in mean cognitive test scores over time, in two out of 10 tests scopolamineβinduced decrement was related to subsequent decline.
π SIMILAR VOLUMES
## Abstract ## Objective Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established A
## Abstract ## Objective The aim of the study was to empirically investigate the hypothesis that anxiety in the elderly, secondary to loss of memory, predicts future cognitive decline. ## Method The participants were 137 elderly subjects with no depression or cognitive impairment from a communit
## Abstract ## Background The miniβmental state exam (MMSE) has been used to address questions such as determination of appropriate cutoff scores for differentiation of individuals with intact cognitive function from patients with dementia and rate of cognitive decline. However, little is known ab
## Abstract ## Objective This study was set up to investigate whether neuropsychological tests are able to predict conversion to AD among Mild Cognitive Impairment (MCI) patients. ## Methods At baseline the cognitive part of the Cambridge Examination for Mental Disorders of the Elderly (CAMCOG),